Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/02/2021 18 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/30/2021 11 1
mAb2 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021 1 0
mAb8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021 1 0
ZF2001 Potential treatment - clinical evidence Experimental Vaccine Mar/24/2021 1 0
Mezerein Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Tubocurarine Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Ginkgolide M Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
1-{3-[2-Hydroxy-3-(4-methylpiperidino)propoxy]phenoxy}-3-(4-methylpiperidino)-2-propanol Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021 1 0